Take the pledge to vote

For a better tommorow#AajSawaroApnaKal
  • I agree to receive emails from News18

  • I promise to vote in this year's elections no matter what the odds are.
  • Please check above checkbox.


Thank you for
taking the pledge

Vote responsibly as each vote counts
and makes a diffrence


Issued in public interest by HDFC Life. HDFC Life Insurance Company Limited (Formerly HDFC Standard Life Insurance Company Limited) (“HDFC Life”). CIN: L65110MH2000PLC128245, IRDAI Reg. No. 101 . The name/letters "HDFC" in the name/logo of the company belongs to Housing Development Finance Corporation Limited ("HDFC Limited") and is used by HDFC Life under an agreement entered into with HDFC Limited. ARN EU/04/19/13618
LIVE TV DownloadNews18 App
News18 English
News18 » Lifestyle
1-min read

This Device Restores Cardiac Function Post Heart-Attack

The device called "Therepi" contains a sponge-like reservoir that attaches directly to the damaged heart tissue.


Updated:June 13, 2018, 12:23 PM IST
facebookTwitter Pocket whatsapp
This Device Restores Cardiac Function Post Heart-Attack
Representative Image

A team of researchers from MIT have developed a novel refillable, implantable device that can be directly attached to a damaged heart and deliver drugs to treat the after-effects of a heart attack.

The device called "Therepi" contains a sponge-like reservoir that attaches directly to the damaged heart tissue, and a refill line connects the reservoir to a port on or under the patient's skin where therapies can be injected either by the patient or a healthcare professional, the researchers said.

"After a heart attack we could use this device to deliver therapy to prevent a patient from getting heart failure," said Ellen Roche, Assistant Professor at the Massachusetts Institute of Technology.

"If the patient already has some degree of heart failure, we can use the device to attenuate the progression," she added.

The reservoir can be implanted on the heart in just one surgical procedure as well as provides a unique opportunity for administering stem cell therapies. It acts as a cell factory.

Therepi, described in the journal Nature Biomedical Engineering, also addresses the problems with current drug delivery methods by administering localised, non-invasive therapies as many times as needed.

In a rat model, the device was shown to be effective in improving cardiac function after a heart attack. The researchers administered multiple doses of cells to a damaged heart throughout a four-week period.

The hearts that received multiple dosages of cells via therapy had more cardiac function than those who received only a single injection or no treatment at all.

Therepi could also be used as a tool to identify the exact dosage appropriate for a host of conditions, the researchers said.

Get the best of News18 delivered to your inbox - subscribe to News18 Daybreak. Follow News18.com on Twitter, Instagram, Facebook, Telegram, TikTok and on YouTube, and stay in the know with what's happening in the world around you – in real time.

| Edited by: Mugdha Kapoor Safaya
Read full article
Next Story
Next Story

facebookTwitter Pocket whatsapp

Live TV

Countdown To Elections Results
To Assembly Elections 2018 Results
Listen to the latest songs, only on JioSaavn.com